SCA Pharmaceuticals Recalls Vancomycin HCl IV Bags Due to Particulate Matter
SCA Pharmaceuticals is recalling 50 bags of Vancomycin HCl 1.5 gram IV bags due to the presence of particulate matter.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of at least 4 according to the rubric.
Plain-English summary
SCA Pharmaceuticals is recalling 50 bags of Vancomycin HCl 1.5 gram added to 5% Dextrose 500 mL (Total Approximate Volume 515 mL) for IV use only. The product is identified by NDC 70004-0925-44, Lot 20161221@74, and an expiration date of 2/4/2017. The recall was initiated due to the presence of particulate matter in the product.
This recall is associated with a recent Hospira recall of vancomycin hydrochloride 10gm vials, which was also due to the presence of particulate matter. The affected SCA Pharmaceuticals product was distributed nationwide in the United States.
Healthcare providers and consumers should stop using the affected product and contact SCA Pharmaceuticals or their healthcare provider for further instructions.
The recalled product
- Product
- Vancomycin HCl 1.5 gram added to 5% Dextrose 500 mL Total Approximate Volume 515 mL For IV Use Only, Rx Only , SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0925-44
- Manufacturer
- SCA Pharmaceuticals
- Category
- Drug — Antibiotic
- Hazard
- Affected units
- 50
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 20161221@74
- Exp 2/4/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by SCA Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · SCA Pharmaceuticals
See all →- HighSCA Pharmaceuticals Fentanyl-Bupivacaine Injectable Recall Due to Manufacturing Deviations
FDA (Drugs) · 2023-08-02
- ModerateFDA recalls Oxytocin product for low potency nationwide
FDA (Drugs) · 2023-05-03
- ModerateFentanyl Injection Syringes Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2023-03-08
- ModerateNorepinephrine Injection Recalled Nationwide for Manufacturing Quality Deviations
FDA (Drugs) · 2022-05-11
- ModerateDrug recall: fentanyl and bupivacaine injectable solution manufacturing deviations
FDA (Drugs) · 2022-05-11
Same hazard · particulate matter
See all →- ModerateIMAAVY Injection Recalled for Presence of Particulate Matter
FDA (Drugs) · 2026-10-14
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls Plum Administration Sets Due to Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
Similar recalls
- ModerateDrug recall: Vancomycin HCl injection bags for manufacturing deviations
FDA (Drugs) · 2022-05-11
- SevereHospira Recalls Vancomycin Hydrochloride Injection Due to Cardboard Particulate Matter
FDA (Drugs) · 2016-06-22
- SevereHospira Recalls Vancomycin Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2017-04-12
- HighVancomycin Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2024-04-03
- HighVancomycin IV Bags Recalled Due to Manufacturing Environment Contamination Risk
FDA (Drugs) · 2023-07-26
- SevereLincare Recalls Vancomycin IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08